BROOKSNSEBrooks Laboratories Limited· PharmaceuticalsMediumNeutral
Announced Thu, 2 Apr · 11:14 IST

Significant movement in price has been observed in Brooks Laboratories Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Brooks Laboratories Limited has submitted their response.

BROOKS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+43.8%1-day move
₹44.53
prior close
₹51.25
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.2-0.5-1.2-1.6+43.8+63.9+59.8+61.5+61.7+58.7+44.8+21.3+51.4+70.5
Up moveDown movePending
AI summary

The NSE noticed unusual price movement in Brooks Laboratories' shares and wrote to the company on April 1, 2026 asking for an explanation. In its response on April 2, 2026, the company stated that it has already disclosed all material information required under SEBI's Listing Regulations. The company confirmed there is no pending Unpublished Price Sensitive Information (UPSI) that could explain the price change. Management said they are unaware of any specific reason behind the movement in share price and volumes, attributing it purely to market dynamics. The clarification was signed by Company Secretary Krutika Rane.

Likely market impact

This is a standard boilerplate response confirming no hidden negative information is being withheld, which is mildly reassuring for shareholders. However, since the actual reason for the price move remains unexplained, the stock may remain volatile until the market finds its own catalyst.